Diffusion Pharmaceuticals Inc
DFFN·Stocks·Miscellaneous Commercial Services·United States·Nasdaq·USD
Price
$0.70
Today
+9.8%
YTD
+0.0%
About
With headquarters in Charlottesville, Virginia, Diffusion Pharmaceuticals is a healthcare firm that operates within the US. The firm works to develop treatments for life-threatening medical conditions. Founded in 2001, the firm's lead product candidate is transcrocetinate sodium. Its stocks are available on the NASDAQ CM stock market, carrying the ticker DFFN. Add this instrument to your eToro watchlist to remain updated on DFFN share price changes.
Price chart
Closing price history for DFFN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.53
P/S (TTM)2529.67
P/B (TTM)1.27
Market cap$22.09M
Cap tierMicro-cap
Industry avg P/E41.97
Profitability
Gross marginUnknown
EBIT margin-334924.82%
Net margin-92680.38%
ROE-131.52%
ROA-109.81%
Earnings & Revenue
Revenue (TTM)$8,726.00
Revenue growth (1Y)-99.9%
EPS (TTM)-$2.77
Free cash flow$-26.59M
Total debt$0.00
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.54
Employees15
Next earnings10 Nov '22
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.